0 Comentários
0 Compartilhamentos
751 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Histone Deacetylase Inhibitors Market Advances with Growing Epigenetic Research and Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market research report includes a...0 Comentários 0 Compartilhamentos 171 Visualizações 0 Anterior
-
Ipilimumab Market Advances with Expanding Immuno-Oncology Research and Growing Adoption of Targeted Cancer TherapiesAccording to the latest report published by Data Bridge Market Research, the Ipilimumab Market The global Ipilimumab market size was valued at USD 2.14 billion in 2025and is expected to reach USD 4.58 billion by 2033, at a CAGR of 10.00% during the forecast period Global Ipilimumab Market report analyses the key developments taking place with respect to agreements, partnerships,...0 Comentários 0 Compartilhamentos 304 Visualizações 0 Anterior
-
MET Inhibitor Drug Market Growth and Oncology Research Trends" MET Inhibitor Drug Market Summary: According to the latest report published by Data Bridge Market Research, the MET Inhibitor Drug Market The global MET Inhibitor Drug market size was valued at USD 1.89 billion in 2025 and is expected to reach USD 5.94 billion by 2033, at a CAGR of 15.40% during the forecast period The market research data...0 Comentários 0 Compartilhamentos 382 Visualizações 0 Anterior
-
SERD (Selective Estrogen Receptor Degrader) Drug Market Advances with Next-Generation Endocrine Therapies and Oncology ResearchAccording to the latest report published by Data Bridge Market Research, the SERD (Selective Estrogen Receptor Degrader) Drug Market The global SERD (Selective Estrogen Receptor Degrader) drug market size was valued at USD 2.84 billion in 2025 and is expected to reach USD 8.93 billion by 2033, at a CAGR of 15.40% during the forecast period The wide ranging SERD (Selective Estrogen...0 Comentários 0 Compartilhamentos 231 Visualizações 0 Anterior
-
Streptozocin Market Advances with Ongoing Oncology Research and Expanding Focus on Rare Cancer TherapeuticsAccording to the latest report published by Data Bridge Market Research, the Streptozocin Market The global streptozocin market size was valued at USD 159.40 million in 2025 and is expected to reach USD 232.83 million by 2033, at a CAGR of 4.85% during the forecast period This Streptozocin Market document encompasses several market aspects such as market estimates and forecasts,...0 Comentários 0 Compartilhamentos 262 Visualizações 0 Anterior
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Global Oncology Information System Market to Reach $4.65 Billion by 2033Market Overview The global oncology information system market size was valued at USD 2.43 billion in 2024 and it is projected to reach from USD 2.61 billion in 2025 to USD 4.65 billion by 2033, growing at a CAGR of 7.5% during the forecast period (2025-2033). The global Oncology Information System market continues to evolve rapidly, driven by...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Strong Market Fundamentals Support the Upward Trajectory of the Interventional Oncology MarketPolaris Market Research has published a new report titled that delivers up-to-date analysis with analyses of the current and future effects of the continuously changing industry landscape. This in-depth, object-oriented business research offers a thorough examination of local market expansion, competition, and global and regional Interventional Oncology Market size, share, and growth....0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
© 2026 Sex Doll Social
Portuguese (Brazil)
Portuguese (Brazil)
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek